EUR/USD to remain confined within 1.1950-1.2350 range – Westpac

FXStreet Team FXStreet

Sluggish EUR/USD rebound reflects a slower distribution of both Recovery Funds and covid vaccines. Economists at Westpac believe the 1.1950-1.2350 range is likely to persist into the European Central Bank (ECB) meeting on Thursday, March 11.

See: EUR/USD to grind higher this year – HSBC

Key quotes

“The EU’s covid vaccine rollout has suffered several logistic and bureaucratic obstacles. Although the total administered vaccines across the region now total almost 35 M, this is quite a shortfall compared to early hopes and is decidedly less than UK (>21 M) and US (>85 M).”

“Regional lockdown restrictions may be on the cusp of being relaxed, but there are growing concerns over the persistence of new COVID-19 cases as new variants take hold. The economic consequence is a potential delay in recoveries which could undermine the optimism which had been featured in recent PMIs.”

“The ECB has underscored that it will maintain PEPP flexibility and that it has further policy tools to provide support if needed. This may well be a feature as the ECB meets next week.”

“EUR/USD is likely to remain contained within an effective 1.1950-1.2350 range.”

Author

FXStreet Team

FXStreet

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak.

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.